Quick Answer
PRECISION BIOSCIENCES INC reported Stockholders Equity of $92.25 million for the year ending 2025.
- PRECISION BIOSCIENCES INC showed an increase of +63.6% in Stockholders Equity from 2024 to 2025.
- This data is from PRECISION BIOSCIENCES INC's annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: -$35.21 million | Q2 2018: $41.11 million | Q3 2018: $53.59 million | Q1 2019: $10.83 million | Q2 2019: $173.98 million | Q3 2019: $155.79 million | Q1 2020: $115.03 million | Q2 2020: $85.60 million | Q3 2020: $63.82 million | Q1 2021: $58.82 million | Q2 2021: $100.55 million | Q3 2021: $101.44 million | Q1 2022: $69.66 million | Q2 2022: $103.02 million | Q3 2022: $84.38 million | Q1 2023: $40.18 million | Q2 2023: $34.04 million | Q3 2023: $29.06 million | Q1 2024: $37.21 million | Q2 2024: $74.71 million | Q3 2024: $64.87 million | Q1 2025: $49.34 million | Q2 2025: $34.05 million | Q3 2025: $16.63 million.
- Over the full 9 years of available data (2017 to 2025), PRECISION BIOSCIENCES INC's Stockholders Equity has grown by 449.8%.
- Historical annual values: Fiscal year 2025: $92.25 million | Fiscal year 2024: $56.39 million | Fiscal year 2023: $18.86 million | Fiscal year 2022: $60.43 million | Fiscal year 2021: $91.17 million | Fiscal year 2020: $44.43 million | Fiscal year 2019: $138.31 million | Fiscal year 2018: $39.96 million | Fiscal year 2017: -$26.37 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: